feed,title,long_url,short_url
Benzinga,Pfizer/Eli Lilly's Tanezumab Safety Profile Fails To Impress FDA Even After 15 Years Of Development Across 41 Trials,https://benzinga.com/general/biotech/21/03/20281330/pfizereli-lillys-tanezumab-safety-profile-fails-to-impress-fda-even-after-15-years-of-development,https://j.mp/3lIcJqK
